Third Parties and Contracts

All research studies and clinical trials taking place in Beaumont Hospital which have been approved by an external recognised research ethics committee, including a national research ethics committee, are required to follow the site sign off process.

A percentage of research studies and clinical trials taking place in Beaumont Hospital which have been approved locally by the Beaumont Hospital Research Ethics Committee also follow this process. This typically occurs either when there is a document which requires the signature of the Beaumont Hospital CEO and/or when there is a third party involved.

Examples of third party involvement include a third party sponsor, a third party funder, a third party data controller, or a third party data processor.

[A reminder that it is possible for a university to be a third party sponsor, funder, data controller or processor.]

Examples of contracts or agreements which are entered into with third parties include clinical trial agreements, material/data transfer agreements and data processing agreements. Such agreements are typically drafted by the third party and delineate the responsibilities of the third party and of the hospital. The hospital arranges for legal review prior to CEO signature as part of the site sign off process.

There has been an increase in the number of research-related contracts being entered into by the hospital in general, and this can be attributed to GDPR requirements.

It is important not to send samples or data outside the hospital without an appropriate contract being agreed and signed by the hospital CEO.